(Q44692619)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Infliximab-induced lupus in Crohn's disease: a case report (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

Piercarlo Sarzi-Puttini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Sandro Ardizzone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

G Manzionna

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

F Atzeni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

E Colombo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

M Antivalle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

M Carrabba

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

G Bianchi-Porro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

814-817

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

Novel therapies for inflammatory bowel disease

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Perianal fistulae following infliximab treatment: clinical and endosonographic outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Infliximab in treatment of Crohn's disease: the Milan experience

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Lamotrigine-induced lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Anti-tumor necrosis factor therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

Etiology and mechanisms of drug-induced lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900448-1

7 January 2021

10.1016/S1590-8658(03)00448-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14674674%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference